Upstate Active Clinical Trials

Study Title:

RTOG-3507 - KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (Keytruda®) PLUS Stereotactic Re-Irradiation versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma

What is the purpose of the study? (in Layman's terms, please describe the study)

The purpose of this study is to compare any good and bad effects of using the study drug plus radiation therapy to using radiation therapy alone.

Upstate Institutional Review Board (IRB) Number:

1881000

Study/Protocol ID:

RTOG-3507

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Seung Shin Hahn, MD

What is involved if I participate?

• How long is the study?
  5 years
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  Yes
• What tests and procedures are involved?
  Please contact the CRA for more information.

Where will the study take place?

Oneida Medical Oncology, Oneida Radiation Oncology, Oswego Medical Oncology, Oswego Radiation Oncology, The Hill Medical Center Radiation Oncology

Other Information:

Please contact the CRA for more information.

ClinicalTrials.Gov ID:

NCT03546582

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Laine Abernathy
Phone: 315-464-6528
Email: [email protected]

Return to Previous Page || Search Again